This is a type of arthritis that affects the bones of the spine and chest wall. It causes pain and stiffness, but you can't see it on regular X-rays. It often starts in young adults and can sometimes lead to a more severe form called ankylosing spondylitis over time.
Every report comes from a Lived member, sent anonymously.
Have you tried Cimzia (Certolizumab Pegol) for Non-Radiographic Axial Spondyloarthritis?
Non-radiographic axial spondyloarthritis (nr-axSpA) is a form of inflammatory arthritis that mainly affects the spine and the sacroiliac joints, where the base of the spine meets the pelvis. Its typical symptom is long-lasting pain and stiffness in the lower back and buttocks that comes on gradually, is often worse at night or first thing in the morning, and tends to ease with movement rather than rest. Fatigue is common, and the neck, hips, ribs, heels and other joints can also be affected. The name describes what tests show. "Axial" refers to the spine and pelvis, and "non-radiographic" means that x-rays do not show definite damage to the sacroiliac joints. When that damage is visible, the condition is called ankylosing spondylitis. The two are best understood as parts of one disease, axial spondyloarthritis, and people with nr-axSpA can have pain and stiffness as severe as people with ankylosing spondylitis. The same inflammation can also involve the eyes (uveitis), the skin (psoriasis) or the gut (inflammatory bowel disease).
The exact cause is not known. Nr-axSpA is an immune-driven condition in which genes play a large part. A gene variant called HLA-B27 (a version of a gene that helps the immune system recognize threats) is strongly linked to it: it is found in a large share of people with nr-axSpA, but it is also common in people who never develop the disease, so carrying it does not mean someone will get it. Symptoms usually begin in young adulthood, before age 45. Unlike ankylosing spondylitis, which is more common in men, nr-axSpA affects women and men in roughly equal numbers. Having a relative with spondyloarthritis, or having psoriasis or inflammatory bowel disease yourself, makes it more likely. Long periods of inactivity, overexertion, poor sleep or stress may make a flare feel worse, but they do not cause the condition.
No single test confirms nr-axSpA, which is one reason diagnosis often takes years. A rheumatologist (a doctor who specializes in arthritis and immune joint diseases) pieces it together from the pattern of back pain, a physical exam, personal and family history, blood tests and imaging. Blood tests usually include HLA-B27 and C-reactive protein (CRP), a marker of inflammation. A positive HLA-B27 result supports the diagnosis but does not prove it, and blood tests and the physical exam are often normal even when the disease is active. X-rays of the pelvis are often taken first. A normal x-ray does not rule out nr-axSpA, because inflammation usually appears well before joint damage. Magnetic resonance imaging (MRI) of the sacroiliac joints can show that inflammation directly. MRI findings still need expert interpretation, because similar-looking changes can appear in people who do not have the condition.
Treatment aims to ease pain and stiffness, keep the spine flexible and help people stay active at work and home. Regular exercise and physical therapy are a foundation of care. A physical therapist can teach stretching, posture and strengthening routines that people then continue at home, and active exercise does more than passive treatments such as massage or heat. Nonsteroidal anti-inflammatory drugs (NSAIDs), such as naproxen or ibuprofen at prescription doses, are the first medicines tried and help many people noticeably. Taking them daily over long periods needs to be weighed against stomach, kidney and heart risks, so the dose and schedule are agreed with a clinician. Long-term steroid pills and arthritis medicines such as methotrexate do little for spine symptoms. If symptoms stay active after trying at least two NSAIDs and there are objective signs of inflammation, such as a raised CRP or inflammation on MRI, the next step is usually a biologic medicine given by injection. Biologics for nr-axSpA come from two main families. Tumor necrosis factor (TNF) inhibitors, such as certolizumab pegol (Cimzia), block one of the main inflammatory signals. Interleukin-17 (IL-17) inhibitors, such as secukinumab (Cosentyx), ixekizumab (Taltz) and bimekizumab (Bimzelx), block a different one. Upadacitinib (Rinvoq), a daily pill from a group called Janus kinase (JAK) inhibitors, is an option when a TNF inhibitor has not worked or was not tolerated. The choice can depend on related conditions. TNF inhibitors of the antibody type, which include Cimzia, are often preferred for people with recurring uveitis or inflammatory bowel disease, and IL-17 inhibitors can make inflammatory bowel disease worse. IL-17 inhibitors are often preferred for people with significant psoriasis. These medicines calm the immune system, so they raise the risk of serious infections. Screening for tuberculosis and other infections comes before starting, and infections during treatment need prompt attention.
Nr-axSpA is usually long-term, and its course varies a great deal. Some people have occasional flares with long quiet periods, while others have persistent pain and stiffness in several areas. Symptoms can change from day to day, and morning stiffness, fatigue and disturbed sleep often affect work and daily routines more than other people realize. Some people with nr-axSpA later develop the x-ray changes of ankylosing spondylitis, but many do not. Studies estimate that about 5% to 30% progress over periods ranging from 2 to 30 years. The range is wide because studies differ, and progression is hard to predict for any one person. A high CRP, marked inflammation on MRI and male sex are linked to a greater chance of progression. With effective treatment, many people stay active and working. Regular exercise remains important even when symptoms are controlled. Seeing a rheumatologist at least once a year, even when things are going well, helps track symptoms, side effects and related problems. Stopping a biologic after a good response often leads to symptoms returning, so any change is best planned with the care team.
See a clinician, ideally a rheumatologist, if back or buttock pain has lasted for months, started before age 45, is worse in the morning or at night and improves with movement. This is especially worth raising if you also have psoriasis, inflammatory bowel disease, past eye inflammation or a relative with spondyloarthritis. Contact your care team promptly if a flare is not settling with your usual treatment, if NSAIDs cause stomach problems, or if you develop a fever or other signs of infection while taking a biologic or JAK inhibitor. A painful red eye, sensitivity to light or blurred or reduced vision can be uveitis, a common complication. Get an eye exam the same day, ideally with an ophthalmologist, because prompt treatment helps protect vision.
Last reviewed • Oct 2026
Educational content, not medical advice.
Our journeys start somewhere and I always hear that autoimmune diseases and chronic pain conditions can be misdiagnosed or not diagnosed at all for years.